Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
GlaxoSmithKline |
---|---|
Information provided by: | GlaxoSmithKline |
ClinicalTrials.gov Identifier: | NCT00046449 |
A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder
Condition | Intervention | Phase |
---|---|---|
Seasonal Affective Disorder (SAD) |
Drug: Investigational Seasonal Affective Disorder (SAD) Drug |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria: (Patient must meet these criteria in order to be eligible for this study.)
Exclusion Criteria: (Patient cannot meet these criteria in order to be eligible for this study.)
Study ID Numbers: | 398149 |
Study First Received: | September 30, 2002 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00046449 |
Health Authority: | United States: Food and Drug Administration |
Seasonal Affective Disorder Depression Mental Disorders Mood Disorders Depressive Disorder |
Pathologic Processes Disease |